PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

Peng, Yanghong; Li, Yijun; Tian, Yu; Ao, Guokun

doi:10.7150/jca.24079



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2018; 9(13):2389-2396. doi:10.7150/jca.24079 This issue Cite

Research Paper

PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma

Yanghong Peng^1#, Yijun Li^2#, Yu Tian³, Guokun Ao^1✉

1. Department of Radiology, the 309th Hospital of Chinese People's Liberation Army, Beijing 100091, P.R. China
2. Department of Gastroenterology, Xi'an Central Hospital, Xian 710010, P.R. China
3. Department of Gastroenterology, the 6th Affiliated Hospital of Xinjiang Medical University, Urumchi 830002, P.R. China
#Contributed equally

Citation:

Peng Y, Li Y, Tian Y, Ao G. PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. J Cancer 2018; 9(13):2389-2396. doi:10.7150/jca.24079. https://www.jcancer.org/v09p2389.htm

Other styles

Abstract

Phosphodiesterases (PDEs) was found to be involved in a variety of cancer pathologies by modulating the degradation of levels of cAMP/cGMP. However, the prognostic significance and biological effect of PDE4a in hepatocellular carcinoma (HCC) have not been understood completely. In the present study, PDE4a expression was detected in a cohort of HCC and matched adjacent liver tissues (n = 210) by immunohistochemistry staining and Western immunoblotting assay, And in vitro experiments were conducted to determine the effect of PDE4a on metastatic capacity of HCC cells. The data here displayed that the majority of HCC patients had higher PDE4a expression in tumor tissues compared to matched adjacent liver tissues and enhanced PDE4a expression in tumor tissues was associated positively with HBV infection, liver cirrhosis, higher serum AFP level, advanced TNM stage, vascular embolus, intrahepatic metastases and portal vein tumor thrombus (PVTT). Survival analyses suggested that higher PDE4a was indicated the poor prognosis of HCCs after liver resection. Ectopic expression of PDE4a in Huh7 cells leaded to significant repression of E-cadherin and up-regulated the expression of N-cadherin and Vimentin, and facilitated migration and invasion abilities. Silencing PDE4a in MHCC97h cells acquired the opposite results. Taken together, PDE4a triggered EMT in HCC cells and acted as a predictive factor candidate and a potential therapeutic target for HCC.

Keywords: PDE4a, hepatocellular carcinoma, clinical outcomes, EMT

Citation styles

APA

Peng, Y., Li, Y., Tian, Y., Ao, G. (2018). PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Journal of Cancer, 9(13), 2389-2396. https://doi.org/10.7150/jca.24079.

ACS

Peng, Y.; Li, Y.; Tian, Y.; Ao, G. PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. J. Cancer 2018, 9 (13), 2389-2396. DOI: 10.7150/jca.24079.

NLM

CSE

Peng Y, Li Y, Tian Y, Ao G. 2018. PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. J Cancer. 9(13):2389-2396.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.